Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

A mathematical model describes the malignant transformation of low grade gliomas: Prognostic implications.

Bogdańska MU, Bodnar M, Piotrowska MJ, Murek M, Schucht P, Beck J, Martínez-González A, Pérez-García VM.

PLoS One. 2017 Aug 1;12(8):e0179999. doi: 10.1371/journal.pone.0179999. eCollection 2017.

2.

Reducing radiation dose to normal brain through a risk adapted dose reduction protocol for patients with favourable subtype anaplastic glioma.

Back M, LeMottee M, Crasta C, Bailey D, Wheeler H, Guo L, Eade T.

Radiat Oncol. 2017 Mar 2;12(1):46. doi: 10.1186/s13014-017-0782-3.

3.

Biomarkers in NOA-04: another piece to the puzzle.

Lassman AB, Cloughesy TF.

Neuro Oncol. 2016 Nov;18(11):1467-1469. No abstract available.

PMID:
27738177
4.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJ, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.

Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.

PMID:
27686946
5.

Comparison of long-term survival between temozolomide-based chemoradiotherapy and radiotherapy alone for patients with low-grade gliomas after surgical resection.

Gai XJ, Wei YM, Tao HM, An DZ, Sun JT, Li BS.

Onco Targets Ther. 2016 Aug 17;9:5117-21. doi: 10.2147/OTT.S108989. eCollection 2016.

6.

Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.

Yamoah K, Showalter TN, Ohri N.

Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):737-45. doi: 10.1016/j.ijrobp.2015.07.2284. Epub 2015 Oct 19. Review.

7.

Neurosurgical management of adult diffuse low grade gliomas in Canada: a multi-center survey.

Khan OH, Mason W, Kongkham PN, Bernstein M, Zadeh G.

J Neurooncol. 2016 Jan;126(1):137-49. doi: 10.1007/s11060-015-1949-0. Epub 2015 Oct 10.

8.

Overall survival in adult patients with low-grade, supratentorial glioma: Ten years' follow up at a single institution.

Kashi AS, Rakhsha A, Houshyari M.

Electron Physician. 2015 Jul 20;7(3):1114-20. doi: 10.14661/2015.1114-1120. eCollection 2015 Jul.

9.

Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.

Sarmiento JM, Venteicher AS, Patil CG.

Cochrane Database Syst Rev. 2015 Jun 29;(6):CD009229. doi: 10.1002/14651858.CD009229.pub2. Review.

10.

Radiation Therapy Oncology Group 9802: Controversy or Consensus in the Treatment of Newly Diagnosed Low-Grade Glioma?

Laack NN, Sarkaria JN, Buckner JC.

Semin Radiat Oncol. 2015 Jul;25(3):197-202. doi: 10.1016/j.semradonc.2015.02.004. Epub 2015 Feb 21. Review.

11.

Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.

Kim MM, Lawrence TS, Cao Y.

Semin Radiat Oncol. 2015 Jul;25(3):172-80. doi: 10.1016/j.semradonc.2015.02.003. Epub 2015 Feb 21. Review.

12.

Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424.

Fisher BJ, Hu C, Macdonald DR, Lesser GJ, Coons SW, Brachman DG, Ryu S, Werner-Wasik M, Bahary JP, Liu J, Chakravarti A, Mehta M.

Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):497-504. doi: 10.1016/j.ijrobp.2014.11.012. Epub 2015 Jan 30.

13.

Survival and low-grade glioma: the emergence of genetic information.

Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M.

Neurosurg Focus. 2015 Jan;38(1):E6. doi: 10.3171/2014.10.FOCUS12367.

14.

Management of elderly patients with gliomas.

Gállego Pérez-Larraya J, Delattre JY.

Oncologist. 2014 Dec;19(12):1258-67. doi: 10.1634/theoncologist.2014-0170. Epub 2014 Oct 23. Review.

15.

New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.

Duffau H, Taillandier L.

Neuro Oncol. 2015 Mar;17(3):332-42. doi: 10.1093/neuonc/nou153. Epub 2014 Aug 2. Review.

16.

Clinical prognostic factors of adjuvant radiation therapy for low-grade gliomas: results of 10 years survival.

Kaya V, Aksu MG, Korcum AF, Ozdemir B, Ceçen Y, Sindir B, Genç M.

Int J Clin Exp Med. 2014 May 15;7(5):1336-43. eCollection 2014.

17.

Peritumoral epilepsy: relating form and function for surgical success.

Cowie CJ, Cunningham MO.

Epilepsy Behav. 2014 Sep;38:53-61. doi: 10.1016/j.yebeh.2014.05.009. Epub 2014 Jun 2. Review.

18.

Low-grade gliomas.

Forst DA, Nahed BV, Loeffler JS, Batchelor TT.

Oncologist. 2014 Apr;19(4):403-13. doi: 10.1634/theoncologist.2013-0345. Epub 2014 Mar 24. Review.

19.

Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.

Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP.

J Clin Oncol. 2014 Feb 20;32(6):535-41. doi: 10.1200/JCO.2013.53.1830. Epub 2014 Jan 13.

20.

Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors.

Mucha-Małecka A, Gliński B, Hetnał M, Jarosz M, Urbański J, Frączek-Błachut B, Dymek P, Małecki K, Chrostowska A.

Rep Pract Oncol Radiother. 2012 Feb 10;17(3):141-5. doi: 10.1016/j.rpor.2012.01.007. eCollection 2012.

Supplemental Content

Support Center